Pliant Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Pliant Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Pliant Therapeutics Inc
Rating: 1.26383325
Author: Trendlyne DVM scores

about

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

1.64 0.02 (1.23%)

89.81% Fall from 52W High

517.8K

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

15.3 / 100

Technically Neutral

35.2 / 100

1Yr Price target upside is 2350%

11 analysts

Pliant Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pliant Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

89.81% Fall from 52W High

SWOT Analysis

Pliant Therapeutics Inc Live Price Chart